Skip to main content

Table 4 Clinical outcomes by age group

From: Elderly patients with atrial fibrillation in routine clinical practice—peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study

Outcome

Age

 < 65 years

Age

 ≥ 65 years

Age

 < 75 years

Age

 ≥ 75 years

Age

 ≥ 65– < 75 years

Age

 ≥ 75– < 85 years

Age

 ≥ 85 years

Total

Number of subjects

280

1162

830

612

550

514

98

1442

All bleeding

11 (3.9%)

39 (3.4%)

29 (3.5%)

21 (3.4%)

18 (3.3%)

17 (3.3%)

4 (4.1%)

50 (3.5%)

MB

1 (0.4%)

5 (0.4%)

3 (0.4%)

3 (0.5%)

2 (0.4%)

3 (0.6%)

0

6 (0.4%)

MB or CRNMB

2 (0.7%)

13 (1.1%)

11 (1.3%)

4 (0.7%)

9 (1.6%)

4 (0.8%)

0

15 (1.0%)

ACS

0

1 (0.1%)

1 (0.1%)

0

1 (0.2%)

0

0

1 (0.1%)

Stroke

0

5 (0.4%)

1 (0.1%)

4 (0.7%)

1 (0.2%)

3 (0.6%)

1 (1.0%)

5 (0.3%)

TIA

0

1 (0.1%)

0

1 (0.2%)

0

1 (0.2%)

0

1 (0.1%)

VTE

0

1 (0.1%)

0

1 (0.2%)

0

1 (0.2%)

0

1 (0.1%)

SEE

0

1 (0.1%)

0

1 (0.2%)

0

1 (0.2%)

0

1 (0.1%)

CV mortality

0

3 (0.3%)

1 (0.1%)

2 (0.3%)

1 (0.2%)

2 (0.4%)

0

3 (0.2%)

All-cause mortality

0

9 (0.8%)

6 (0.7%)

3 (0.5%)

6 (1.1%)

2 (0.4%)

1 (1.0%)

9 (0.6%)